Int. J. Environ. Res. Public Health 2009, 6 221 48. Britton, J.; Knox, A. Helping people to stop smoking: the new smoking cessation guidelines. Thorax 1999, 54, 1-2. 49. Fiore, M.C.; Bailey, W.C.; Cohen, S.J.; Dorfman, S.F.; Fox, B.J.; Goldstein, M.G.; Gritz, E.; Hasselblad, V.; Heyman, R.B.; Jaen, C.R., ‘et al’. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. JAMA 2000, 28, 3244- 3254. 50. Pauwels, R.A.; Buist, A.S.; Ma, P.; Jenkins, C.R.; Hurd, S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Am. J. Respir. Crit. Care Med. 2001, 163, 1256-1276. 51. van Schayck, C.P.; Kaper, J. Smoking and COPD: will they ever vanish into smoke? (Editorial). Primary Care Respir. J. 2006, 15, 81-83 52. Wu, P.; Wilson, K.; Dimoulas, P.; Mills, E.J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006, 6, 300 doi:10.1186/1471-2458-6- 300. 53. Ranney, L.; Melvin, C.; Lux, L.; McClain, E.M.A.; Lohr, K.N. Systematic Review: Smoking Cessation Intervention Strategies for Adults and Adults in Special Populations. Ann. Intern. Med. 2006, 145, 845-856. 54. Nides, M. Update on pharmacologic options for smoking cessation treatment. Am. J. Med. 2008, 121, s20-31. 55. Stead, L.F.; Perera, R.; Bullen, C.; Mant, D.; Lancaster, T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2008, 23, CD000146. 56. Jorenby, D.E.; Leischow, S.J.; Nides, M.A.; Rennard. S.I.; Johnston, J.A.; Hughes, A.R.; Smith, S.S.; Muramoto, M.L.; Daughton, D.M.; Doan, K.; Fiore, M.C.; Baker, T.B. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. 1999, 340, 685-691. 57. McClure, J.B.; Swan, G.E. Tailoring nicotine replacement therapy: rationale and potential approaches. CNS Drugs 2006, 20, 281-91. 58. Aubin, H.J. Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs 2002, 62, 45-52. 59. Hays, J.T.; Ebbert, J.O. Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs 2003, 17, 71-83. 60. Hughes, J.R.; Stead, L.F.; Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 2007, 24, CD000031. 61. Ferry, L.; Johnston, J.A. Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience. Int. J. Clin. Pract. 2003, 57, 224-230. 62. Coe, J.W.; Brooks, P.R.; Vetelino, M.G.; Wirtz, M.C.; Arnold, E.P.; Huang, J.; Sands, S.B.; Davis, T.I.; Lebel, L.A.; Fox, C.B.; Shrikhande, A.; Heym, J.H.; Schaeffer, E.; Rollema, H.; Lu, Y.; Mansbach, R.S.; Chambers, L.K.; Rovetti, C.C.; Schulz, D.W.; Tingley, F.D., III; O'Neill, B.T. Varenicline: an α4b2 nicotinic receptor partial agonist for smoking cessation. J. Med. Chem. 2005, 48, 3474-3477.